The presentation will highlight the relationship between mental health and the onset of COVID-19 in Colorado. This innovative matched reference groups study comprised 7,599 people in both populations and was based on the Trajectory’s epidemiological-based AI software using the Colorado All Payer Claims Data Base. Key population health trends show:

• Preexisting mental health conditions are a strong independent predictor of COVID-19; and
• A mental health diagnosis, in combination with known COVID-19 physical conditions (i.e., diabetes, asthma, chronic obstructive pulmonary disease, chronic kidney disease, and hypertension) acts as a strong multiplier on predicting COVID-19 incidence.

We believe this study is among the first to discover that mental/behavioral health in interaction of physical diseases with depression, anxiety, and other related conditions, is a strong predictor of COVID-19. The presentation will feature two nationally known thought leaders in the population health field and will include a respondent panel made of experts in public health, medicine, and health economics.

Pre-print of study available at SSRN: https://ssrn.com/abstract=3807198

Moderator:
• Garry Carneal, JD, MA, CEO Schooner Strategies and PHII Advisory Board Chair

Presenters:
• Thomas Wilson, PhD, DrPH Founder and Chief Science Officer Trajectory Healthcare, LLC and PHII Board Chair
• Janet (Jessie) Sullivan, MD, Principal, SE JNS, LLC; former CMO, Hudson Health Plan (part of NY Medicaid)

Responder(s):
• Rachel Nolan, PhD, Assistant Professor, University of Cincinnati’s College of Medicine
• Patricia Salber, MD, MPH, CEO and Editor-in-Chief of The Doctor Weighs In
• Deborah Viola, MBA, PhD; Vice President, Data Management and Analytics, Westchester Medical Center Health Network

Webinar powered by Schooner Strategies